Cost-effectiveness analysis of screening for type 1 diabetes in children in the Russian Federation

Medical Technologies. Assessment and Choice · Published 2026-06-26 · DOI 10.17116/medtech202648021123

Free full text

Authors (6)

O.S. Golikova, V.V. Omelyanovskiy, E.I. Rumyantseva, K.I. Matrenin, D.N. Laptev, N.G. Mokrysheva

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Golikova, O., Omelyanovskiy, V., Rumyantseva, E., et al. (2026). Cost-effectiveness analysis of screening for type 1 diabetes in children in the Russian Federation. Medical Technologies. Assessment and Choice. https://doi.org/10.17116/medtech202648021123

Related articles

• View of students and residents studying at the university on programs for young specialist support in health care · Medical Technologies. Assessment and Choice · 2025 · Same journal
• The Webiomed.DHRA decision-making support system for medical examinations in the Russian Federation: a cost-effectiveness analysis · Medical Technologies. Assessment and Choice · 2025 · Same journal
• Models of adaptation to professional activity on the example of health care provider · Medical Technologies. Assessment and Choice · 2025 · Same journal
• Early diagnosis and treatment of type 1 diabetes mellitus. Issues of clinical feasibility, organization, and accessibility of medical care. Resolution on the results of the Expert Council held on December 17, 2024, Moscow · Medical Technologies. Assessment and Choice · 2025 · Same journal
• Compliance with short-team follow-up in BI-RADS 3 patients · Medical Technologies. Assessment and Choice · 2025 · Same journal
• Innovation readiness assessment in healthcare organizations · Medical Technologies. Assessment and Choice · 2025 · Same journal
• Experience of telemedicine technologies for pediatric oncology-hematology in the constituent entities of the Russian Federation · Medical Technologies. Assessment and Choice · 2025 · Same journal
• Sales of antipsychotics and anticonvulsants in the Russian Federation for the period 2019—2024 · Medical Technologies. Assessment and Choice · 2026 · Same journal
• Clinical and economic consequences associated with expanding drug reimbursement for patients with chronic obstructive pulmonary disease · Medical Technologies. Assessment and Choice · 2026 · Same journal
• Spiral prototyping concept in optimizing drug supply in national project «The fight against cardiovascular diseases» · Medical Technologies. Assessment and Choice · 2026 · Same journal